Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis

Abstract

MRI brain lesions at presentation with optic neuritis (ON) increase the risk for developing clinically definite (CD) multiple sclerosis (MS). More detailed early MRI findings may improve prediction of conversion.

The objectives of this study were to investigate the influence of number, location and activity of lesions at presentation, new lesions at early follow-up and non-lesion MRI measures on conversion from optic neuritis (ON) to CDMS.

142/143 ON patients, prospectively recruited into a serial MRI and clinical follow-up study, were followed-up at least once. Cox regression analysis determined independent early MRI predictors of time to CDMS from: (i) baseline lesion number, location and activity measures, (ii) three-month lesion activity measures and (iii) brain atrophy, magnetization transfer ratio and spectroscopy measures.

114/142 (80%) had abnormal baseline brain or cord MRI. 57 (40%) developed CDMS (median of 16 months from clinically isolated syndrome onset). Median follow-up of the non-converters was 62 months. Multivariate analysis of baseline parameters revealed gender, periventricular and gadolinium-enhancing lesions as independent predictors of CDMS. Considering both scans together, gender, baseline periventricular and new T2 lesions at follow-up remained significant (hazard ratios 2.1, 2.4 and 4.9, respectively). No non-conventional measure predicted CDMS.

It was concluded that new T2 lesions on an early follow-up scan were the strongest independent predictor of CDMS.

Keywords

optic neuritis multiple sclerosis early MRI magnetization transfer ratio spectroscopy atrophy

References

Brex PA , Ciccarelli O. , O’Riordan JI , Sailer M. , Thompson AJ , Miller DH , et al. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002 ; 346(3): 158-164.

Tintore M. , Rovira A. , Rio J. , et al. Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology 2006; 67(6): 968-972.

Minneboo A. , Barkhof F. , Polman CH , Uitdehaag BM , Knol DL , Castelijns JA Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. Arch Neurol 2004; 61(2): 217-221.

Beck RW , Trobe JD , Moke PS , et al. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 2003; 121(7): 944-949.

Fisniku LK , Brex PA , Altmann DR , et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 2008; 131(3): 808-817.

Francis DA , Compston DA , Batchelor JR , McDonald WI A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up. J Neurol Neurosurg Psychiatry 1987; 50(6): 758-765.

Hutchinson WM Acute optic neuritis and the prognosis for multiple sclerosis. J Neurol Neurosurg Psychiatry 1976 ; 39(3): 283-289.

Barkhof F. , Filippi M. , Miller DH , et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120(11): 2059-2069.

Brex PA , Miszkiel KA , O’Riordan JI , et al. Assessing the risk of early multiple sclerosis in patients with clinically isolated syndromes: the role of a follow up MRI. J Neurol Neurosurg Psychiatry 2001; 70(3): 390-393.

10.

Barkhof F. , Filippi M. , van Waesberghe JH , et al. Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis. Neurology 1997; 49(6): 1682-1688.

11.

Tas MW , Barkhol F. , van Walderveen MA , Polman CH , Hommes OR , Valk J. The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis. AJNR Am J Neuroradiol 1995; 16(2): 259-964.

12.

Morrissey SP , Miller DH , Kendall BE , et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. Brain 1993; 116(1): 135-146.

13.

Brex PA , O’Riordan JI , Miszkiel KA , et al. Multisequence MRI in clinically isolated syndromes and the early development of MS. Neurology 1999; 53(6): 1184-1190.

14.

Thorpe JW , Kidd D. , Moseley IF , et al. Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain 1996; 119(3): 709-714.

15.

Bot JC , Barkhof F. , Polman CH , et al. Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 2004; 62(2): 226-233.

16.

Wattjes MP , Harzheim M. , Lutterbey GG , Bogdanow M. , Schild HH , Traber F. High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis: correlation between metabolic alterations and diagnostic MR imaging criteria. J Neurol 2008; 255(1): 56-63.

17.

Wattjes MP , Harzheim M. , Lutterbey GG , et al. Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis. Neuroradiology 2008; 50(2): 123-129.

18.

Fernando KT , McLean MA , Chard DT , et al. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2004; 127(6): 1361-1369.

19.

Fernando KT , Tozer DJ , Miszkiel KA , et al. Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2005; 128(12): 2911-2925.

20.

Rocca MA , Agosta F. , Sormani MP , et al. A three-year, multi-parametric MRI study in patients at presentation with CIS. J Neurol 2008; 255(5): 683-691.

21.

Ramsaransing G. , Maurits N. , Zwanikken C. , De Keyser J. , et al. Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review. Mult Scler 2001; 7(5): 345-347.

22.

Swanton JK , Fernando KT , Dalton CM , et al. Early MRI in optic neuritis: the risk for disability. Neurology 2009; 72(6): 542-550.

23.

Dalton CM , Brex PA , Jenkins R. , et al. Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis . J Neurol Neurosurg Psychiatry 2002; 73(2): 141-147.

24.

Dalton CM , Chard DT , Davies GR , et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes . Brain 2004; 127(5): 1101-1107.

25.

Tintore M. New options for early treatment of multiple sclerosis. J Neurol Sci 2009; 277(1): S9-S11.

26.

Eriksson M. , Andersen O. , Runmarker B. Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis. Mult Scler 2003; 9(3): 260-274.

27.

Confavreux C. , Vukusic S. , Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003; 126(4): 770-782.

28.

Ebers GC Prognostic factors for multiple sclerosis: the importance of natural history studies. J Neurol 2005; 252(3): iii15-iii20.

29.

Beck RW , Chandler DL , Cole SR , et al. Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses. Ann Neurol 2002; 51(4): 481-490.

30.

Comi G. , Filippi M. , Barkhof F. , et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 2001; 357(9268): 1576-1582.

31.

Kappos L. , Freedman MS , Polman CH , et al. Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study. Lancet 2007; 370(9585): 389-397.

32.

Rovaris M. , Gambini A. , Gallo A. , et al. Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution. Neurology 2005; 65(10): 1626-1630.

33.

Hubbers CU , Clemen CS , Kesper K. , et al. Pathological consequences of VCP mutations on human striated muscle. Brain 2007; 130(2): 381-393.

34.

Audoin B. , Ibarrola D. , Malikova I. , et al. Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis - a two-year longitudinal MRI/ MRSI study of corpus callosum. Mult Scler 2007; 13(1): 41-51.

35.

De Stefano N. , Matthews PM , Fu L. , et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 1998; 121(8): 1469-1477.

36.

Rovaris M. , Agosta F. , Sormani MP , et al. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. Brain 2003; 126(10): 2323-2332.

37.

Agosta F. , Rovaris M. , Pagani E. , Sormani MP , Comi G. , Filippi M. , et al. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain 2006; 129(10): 2620-2627.

38.

Rizzo JF 3rd , Lessell S. Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study. Neurology 1988; 38(2): 185-190.

39.

Kinnunen E. The incidence of optic neuritis and its prognosis for multiple sclerosis. Acta Neurol Scand 1983; 68(6): 371-377.

40.

Tintore M. , Rovira A. , Rio J. , et al. Is optic neuritis more benign than other first attacks in multiple sclerosis? Ann Neurol 2005; 57(2): 210-215.

41.

Weinshenker BG Natural history of multiple sclerosis. Ann Neurol 1994; 36(Suppl): S6-11.

42.

Sailer M. , O’Riordan JI , Thompson AJ , et al. Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. Neurology 1999 ; 52(3): 599-606.

43.

Freeborough PA , Fox NC , Kitney RI Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Comput Methods Programs Biomed 1997; 53(1): 15-25.

44.

Barker GJ , Tofts PS , Gass A. An interleaved sequence for accurate and reproducible clinical measurement of magnetization transfer ratio. Magn Reson Imaging 1996; 14(4): 403-411.